Safety, PK and Effectiveness of IV Peramivir Versus Oseltamivir in Pediatric Subjects With Uncomplicated Influenza
Status:
Completed
Trial end date:
2020-05-14
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety, pharmacokinetics and effectiveness of a single dose of
IV peramivir compared to a standard 5 day course of oral oseltamivir in the treatment of
pediatric subjects with acute uncomplicated influenza.